日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/01/26 | 日証協 | 378,116株 | +14.93% | 72,444株 | -3.55% | 408,345株 | +10.29% | 47,985株 | -31.75% |
2018/01/19 | 日証協 | 329,006株 | +6.73% | 75,108株 | +137.22% | 370,235株 | +12.56% | 70,304株 | +633.86% |
2018/01/12 | 日証協 | 308,274株 | -5.31% | 31,662株 | +427.7% | 328,911株 | -2.86% | 9,580株 | -70.83% |
2018/01/05 | 日証協 | 325,574株 | +2.17% | 6,000株 | -91.36% | 338,608株 | +7.74% | 32,844株 | -58.73% |
2017/12/29 | 日証協 | 318,660株 | -0.78% | 69,462株 | -2.52% | 314,270株 | +12.26% | 79,575株 | +169.62% |
2017/12/22 | 日証協 | 321,168株 | +5.83% | 71,258株 | -44.53% | 279,956株 | -9.45% | 29,514株 | +34.64% |
2017/12/15 | 日証協 | 303,468株 | -26.46% | 128,472株 | -8.98% | 309,156株 | -16.38% | 21,921株 | -58.87% |
2017/12/08 | 日証協 | 412,656株 | +10.81% | 141,140株 | -44.73% | 369,735株 | -1.15% | 53,300株 | +2.04% |
2017/12/01 | 日証協 | 372,412株 | +5.38% | 255,362株 | +3092.03% | 374,031株 | +1.73% | 52,236株 | -27.16% |
2017/11/24 | 日証協 | 353,412株 | -0.76% | 8,000株 | -82.32% | 367,677株 | +0.97% | 71,711株 | +20.23% |
2017/11/17 | 日証協 | 356,112株 | -5.07% | 45,259株 | +78.13% | 364,143株 | -0.35% | 59,644株 | +22.9% |
2017/11/10 | 日証協 | 375,112株 | -42.33% | 25,408株 | -89.41% | 365,438株 | -42.4% | 48,530株 | +122.22% |
2017/11/02 | 日証協 | 650,469株 | -2.35% | 239,815株 | -47.91% | 634,443株 | +0.41% | 21,839株 | -52.22% |
2017/10/27 | 日証協 | 666,121株 | +6.68% | 460,349株 | +19.6% | 631,843株 | +2.97% | 45,703株 | +24.87% |
2017/10/20 | 日証協 | 624,405株 | +6.9% | 384,918株 | +7.75% | 613,624株 | -6.6% | 36,600株 | +93.65% |
2017/10/13 | 日証協 | 584,121株 | -9.23% | 357,233株 | +21.14% | 657,004株 | +1.48% | 18,900株 | -55.32% |
2017/10/06 | 日証協 | 643,552株 | +1.07% | 294,885株 | -47.9% | 647,404株 | +4.19% | 42,300株 | +7.9% |
2017/09/29 | 日証協 | 636,755株 | +5.32% | 565,965株 | +178.27% | 621,353株 | -1.53% | 39,203株 | -15.72% |
2017/09/22 | 日証協 | 604,614株 | +16.7% | 203,388株 | +116.65% | 630,987株 | +1.33% | 46,517株 | +281.29% |
※株式分割は考慮していませんのでご注意ください。
Page Top